nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelastine—CYP2A6—Ifosfamide—testicular cancer	0.111	0.147	CbGbCtD
Azelastine—CYP2B6—Ifosfamide—testicular cancer	0.0721	0.0954	CbGbCtD
Azelastine—CYP3A5—Ifosfamide—testicular cancer	0.0568	0.0752	CbGbCtD
Azelastine—CYP2C8—Ifosfamide—testicular cancer	0.0546	0.0723	CbGbCtD
Azelastine—CYP2C19—Ifosfamide—testicular cancer	0.0458	0.0606	CbGbCtD
Azelastine—CYP2C9—Ifosfamide—testicular cancer	0.0381	0.0504	CbGbCtD
Azelastine—CYP2B6—Cisplatin—testicular cancer	0.0351	0.0464	CbGbCtD
Azelastine—ADRA1B—vas deferens—testicular cancer	0.035	0.674	CbGeAlD
Azelastine—CYP2E1—Etoposide—testicular cancer	0.0349	0.0462	CbGbCtD
Azelastine—ABCB1—Dactinomycin—testicular cancer	0.0313	0.0414	CbGbCtD
Azelastine—CYP3A5—Etoposide—testicular cancer	0.0271	0.0359	CbGbCtD
Azelastine—CYP2C8—Etoposide—testicular cancer	0.0261	0.0345	CbGbCtD
Azelastine—CYP2B6—Doxorubicin—testicular cancer	0.0235	0.0311	CbGbCtD
Azelastine—CYP3A4—Ifosfamide—testicular cancer	0.0221	0.0293	CbGbCtD
Azelastine—CYP1A2—Etoposide—testicular cancer	0.0202	0.0267	CbGbCtD
Azelastine—ABCB1—Vinblastine—testicular cancer	0.0196	0.026	CbGbCtD
Azelastine—CYP2C9—Cisplatin—testicular cancer	0.0185	0.0245	CbGbCtD
Azelastine—CYP2D6—Vinblastine—testicular cancer	0.0185	0.0245	CbGbCtD
Azelastine—ABCB1—Cisplatin—testicular cancer	0.018	0.0238	CbGbCtD
Azelastine—ABCB1—Etoposide—testicular cancer	0.0177	0.0234	CbGbCtD
Azelastine—ABCB1—Doxorubicin—testicular cancer	0.012	0.0159	CbGbCtD
Azelastine—CYP3A4—Vinblastine—testicular cancer	0.0117	0.0156	CbGbCtD
Azelastine—ABCB1—Methotrexate—testicular cancer	0.0117	0.0155	CbGbCtD
Azelastine—CYP2D6—Doxorubicin—testicular cancer	0.0114	0.015	CbGbCtD
Azelastine—CYP3A4—Etoposide—testicular cancer	0.0106	0.014	CbGbCtD
Azelastine—CYP3A4—Doxorubicin—testicular cancer	0.00722	0.00956	CbGbCtD
Azelastine—CYP2A6—seminal vesicle—testicular cancer	0.00234	0.045	CbGeAlD
Azelastine—KCNH2—seminal vesicle—testicular cancer	0.00143	0.0276	CbGeAlD
Azelastine—CYP2E1—seminal vesicle—testicular cancer	0.0011	0.0213	CbGeAlD
Azelastine—CYP2B6—gonad—testicular cancer	0.00085	0.0164	CbGeAlD
Azelastine—KCNH2—female gonad—testicular cancer	0.000841	0.0162	CbGeAlD
Azelastine—KCNH2—testis—testicular cancer	0.000746	0.0144	CbGeAlD
Azelastine—CYP1A1—female gonad—testicular cancer	0.000711	0.0137	CbGeAlD
Azelastine—CYP3A5—female gonad—testicular cancer	0.000695	0.0134	CbGeAlD
Azelastine—CYP2C8—testis—testicular cancer	0.000683	0.0132	CbGeAlD
Azelastine—HRH1—female gonad—testicular cancer	0.000674	0.013	CbGeAlD
Azelastine—ABCB1—embryo—testicular cancer	0.000669	0.0129	CbGeAlD
Azelastine—ABCB1—seminal vesicle—testicular cancer	0.000629	0.0121	CbGeAlD
Azelastine—CYP2B6—testis—testicular cancer	0.000612	0.0118	CbGeAlD
Azelastine—HRH1—testis—testicular cancer	0.000598	0.0115	CbGeAlD
Azelastine—CYP2E1—testis—testicular cancer	0.000575	0.0111	CbGeAlD
Azelastine—KCNH2—lymph node—testicular cancer	0.000541	0.0104	CbGeAlD
Azelastine—CYP2D6—female gonad—testicular cancer	0.000513	0.00989	CbGeAlD
Azelastine—CYP1A1—lymph node—testicular cancer	0.000457	0.0088	CbGeAlD
Azelastine—CYP2D6—testis—testicular cancer	0.000455	0.00877	CbGeAlD
Azelastine—ABCB1—gonad—testicular cancer	0.000454	0.00875	CbGeAlD
Azelastine—HRH1—lymph node—testicular cancer	0.000434	0.00835	CbGeAlD
Azelastine—ABCB1—female gonad—testicular cancer	0.000369	0.00711	CbGeAlD
Azelastine—Paraesthesia—Ifosfamide—testicular cancer	0.000353	0.00183	CcSEcCtD
Azelastine—Ill-defined disorder—Etoposide—testicular cancer	0.000353	0.00183	CcSEcCtD
Azelastine—Anxiety—Cisplatin—testicular cancer	0.000353	0.00183	CcSEcCtD
Azelastine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000351	0.00182	CcSEcCtD
Azelastine—Dyspnoea—Ifosfamide—testicular cancer	0.000351	0.00182	CcSEcCtD
Azelastine—Somnolence—Ifosfamide—testicular cancer	0.00035	0.00181	CcSEcCtD
Azelastine—Discomfort—Cisplatin—testicular cancer	0.000349	0.00181	CcSEcCtD
Azelastine—Increased appetite—Doxorubicin—testicular cancer	0.000349	0.00181	CcSEcCtD
Azelastine—Vomiting—Vinblastine—testicular cancer	0.000346	0.0018	CcSEcCtD
Azelastine—Malaise—Etoposide—testicular cancer	0.000343	0.00178	CcSEcCtD
Azelastine—Face oedema—Epirubicin—testicular cancer	0.000342	0.00177	CcSEcCtD
Azelastine—Vertigo—Etoposide—testicular cancer	0.000342	0.00177	CcSEcCtD
Azelastine—Headache—Vinblastine—testicular cancer	0.000341	0.00177	CcSEcCtD
Azelastine—Abdominal pain—Dactinomycin—testicular cancer	0.000339	0.00176	CcSEcCtD
Azelastine—Body temperature increased—Dactinomycin—testicular cancer	0.000339	0.00176	CcSEcCtD
Azelastine—Fatigue—Ifosfamide—testicular cancer	0.000339	0.00176	CcSEcCtD
Azelastine—Anaphylactic shock—Cisplatin—testicular cancer	0.000339	0.00176	CcSEcCtD
Azelastine—Hypersensitivity—Bleomycin—testicular cancer	0.000339	0.00176	CcSEcCtD
Azelastine—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.000339	0.00176	CcSEcCtD
Azelastine—Infection—Cisplatin—testicular cancer	0.000337	0.00175	CcSEcCtD
Azelastine—Pain—Ifosfamide—testicular cancer	0.000336	0.00175	CcSEcCtD
Azelastine—Constipation—Ifosfamide—testicular cancer	0.000336	0.00175	CcSEcCtD
Azelastine—Cough—Etoposide—testicular cancer	0.000332	0.00172	CcSEcCtD
Azelastine—Tachycardia—Cisplatin—testicular cancer	0.000331	0.00172	CcSEcCtD
Azelastine—Asthenia—Bleomycin—testicular cancer	0.00033	0.00171	CcSEcCtD
Azelastine—Hypertension—Etoposide—testicular cancer	0.000329	0.00171	CcSEcCtD
Azelastine—ABCB1—testis—testicular cancer	0.000327	0.00631	CbGeAlD
Azelastine—Asthma—Methotrexate—testicular cancer	0.000327	0.0017	CcSEcCtD
Azelastine—Pruritus—Bleomycin—testicular cancer	0.000326	0.00169	CcSEcCtD
Azelastine—Feeling abnormal—Ifosfamide—testicular cancer	0.000324	0.00168	CcSEcCtD
Azelastine—Chest pain—Etoposide—testicular cancer	0.000324	0.00168	CcSEcCtD
Azelastine—Nausea—Vinblastine—testicular cancer	0.000324	0.00168	CcSEcCtD
Azelastine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000322	0.00167	CcSEcCtD
Azelastine—Discomfort—Etoposide—testicular cancer	0.00032	0.00166	CcSEcCtD
Azelastine—Nasopharyngitis—Epirubicin—testicular cancer	0.000317	0.00164	CcSEcCtD
Azelastine—Face oedema—Doxorubicin—testicular cancer	0.000316	0.00164	CcSEcCtD
Azelastine—Hypersensitivity—Dactinomycin—testicular cancer	0.000316	0.00164	CcSEcCtD
Azelastine—Confusional state—Etoposide—testicular cancer	0.000313	0.00163	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.000312	0.00162	CcSEcCtD
Azelastine—Body temperature increased—Ifosfamide—testicular cancer	0.000311	0.00161	CcSEcCtD
Azelastine—Abdominal pain—Ifosfamide—testicular cancer	0.000311	0.00161	CcSEcCtD
Azelastine—Anaphylactic shock—Etoposide—testicular cancer	0.000311	0.00161	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000309	0.0016	CcSEcCtD
Azelastine—Infection—Etoposide—testicular cancer	0.000309	0.0016	CcSEcCtD
Azelastine—Asthenia—Dactinomycin—testicular cancer	0.000308	0.0016	CcSEcCtD
Azelastine—Asthma—Epirubicin—testicular cancer	0.000306	0.00159	CcSEcCtD
Azelastine—Paraesthesia—Cisplatin—testicular cancer	0.000304	0.00158	CcSEcCtD
Azelastine—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000304	0.00158	CcSEcCtD
Azelastine—Tachycardia—Etoposide—testicular cancer	0.000303	0.00157	CcSEcCtD
Azelastine—Dyspnoea—Cisplatin—testicular cancer	0.000302	0.00157	CcSEcCtD
Azelastine—Bronchitis—Epirubicin—testicular cancer	0.000295	0.00153	CcSEcCtD
Azelastine—Diarrhoea—Dactinomycin—testicular cancer	0.000294	0.00152	CcSEcCtD
Azelastine—Nasopharyngitis—Doxorubicin—testicular cancer	0.000293	0.00152	CcSEcCtD
Azelastine—Vomiting—Bleomycin—testicular cancer	0.000293	0.00152	CcSEcCtD
Azelastine—Rash—Bleomycin—testicular cancer	0.00029	0.00151	CcSEcCtD
Azelastine—Pain—Cisplatin—testicular cancer	0.00029	0.0015	CcSEcCtD
Azelastine—Dermatitis—Bleomycin—testicular cancer	0.00029	0.0015	CcSEcCtD
Azelastine—Hypersensitivity—Ifosfamide—testicular cancer	0.00029	0.0015	CcSEcCtD
Azelastine—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000289	0.0015	CcSEcCtD
Azelastine—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000285	0.00148	CcSEcCtD
Azelastine—Conjunctivitis—Methotrexate—testicular cancer	0.000284	0.00147	CcSEcCtD
Azelastine—Asthma—Doxorubicin—testicular cancer	0.000283	0.00147	CcSEcCtD
Azelastine—Pollakiuria—Epirubicin—testicular cancer	0.000283	0.00147	CcSEcCtD
Azelastine—Asthenia—Ifosfamide—testicular cancer	0.000282	0.00146	CcSEcCtD
Azelastine—Feeling abnormal—Cisplatin—testicular cancer	0.000279	0.00145	CcSEcCtD
Azelastine—Paraesthesia—Etoposide—testicular cancer	0.000279	0.00145	CcSEcCtD
Azelastine—Weight increased—Epirubicin—testicular cancer	0.000279	0.00145	CcSEcCtD
Azelastine—Pruritus—Ifosfamide—testicular cancer	0.000278	0.00144	CcSEcCtD
Azelastine—Haematuria—Methotrexate—testicular cancer	0.000278	0.00144	CcSEcCtD
Azelastine—Dyspnoea—Etoposide—testicular cancer	0.000277	0.00144	CcSEcCtD
Azelastine—Somnolence—Etoposide—testicular cancer	0.000276	0.00143	CcSEcCtD
Azelastine—Epistaxis—Methotrexate—testicular cancer	0.000275	0.00143	CcSEcCtD
Azelastine—Nausea—Bleomycin—testicular cancer	0.000273	0.00142	CcSEcCtD
Azelastine—Vomiting—Dactinomycin—testicular cancer	0.000273	0.00142	CcSEcCtD
Azelastine—Bronchitis—Doxorubicin—testicular cancer	0.000272	0.00141	CcSEcCtD
Azelastine—Rash—Dactinomycin—testicular cancer	0.000271	0.0014	CcSEcCtD
Azelastine—Diarrhoea—Ifosfamide—testicular cancer	0.000269	0.0014	CcSEcCtD
Azelastine—Body temperature increased—Cisplatin—testicular cancer	0.000268	0.00139	CcSEcCtD
Azelastine—Fatigue—Etoposide—testicular cancer	0.000268	0.00139	CcSEcCtD
Azelastine—Constipation—Etoposide—testicular cancer	0.000266	0.00138	CcSEcCtD
Azelastine—Pain—Etoposide—testicular cancer	0.000266	0.00138	CcSEcCtD
Azelastine—Conjunctivitis—Epirubicin—testicular cancer	0.000265	0.00138	CcSEcCtD
Azelastine—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000263	0.00137	CcSEcCtD
Azelastine—Pollakiuria—Doxorubicin—testicular cancer	0.000262	0.00136	CcSEcCtD
Azelastine—Haematuria—Epirubicin—testicular cancer	0.00026	0.00135	CcSEcCtD
Azelastine—Dizziness—Ifosfamide—testicular cancer	0.00026	0.00135	CcSEcCtD
Azelastine—Pharyngitis—Methotrexate—testicular cancer	0.00026	0.00135	CcSEcCtD
Azelastine—Weight increased—Doxorubicin—testicular cancer	0.000258	0.00134	CcSEcCtD
Azelastine—Epistaxis—Epirubicin—testicular cancer	0.000258	0.00134	CcSEcCtD
Azelastine—Sinusitis—Epirubicin—testicular cancer	0.000256	0.00133	CcSEcCtD
Azelastine—Feeling abnormal—Etoposide—testicular cancer	0.000256	0.00133	CcSEcCtD
Azelastine—Nausea—Dactinomycin—testicular cancer	0.000255	0.00132	CcSEcCtD
Azelastine—Gastrointestinal pain—Etoposide—testicular cancer	0.000254	0.00132	CcSEcCtD
Azelastine—Visual impairment—Methotrexate—testicular cancer	0.000252	0.00131	CcSEcCtD
Azelastine—Vomiting—Ifosfamide—testicular cancer	0.00025	0.0013	CcSEcCtD
Azelastine—Hypersensitivity—Cisplatin—testicular cancer	0.00025	0.0013	CcSEcCtD
Azelastine—Rash—Ifosfamide—testicular cancer	0.000248	0.00129	CcSEcCtD
Azelastine—Dermatitis—Ifosfamide—testicular cancer	0.000248	0.00129	CcSEcCtD
Azelastine—Rhinitis—Epirubicin—testicular cancer	0.000246	0.00127	CcSEcCtD
Azelastine—Body temperature increased—Etoposide—testicular cancer	0.000246	0.00127	CcSEcCtD
Azelastine—Abdominal pain—Etoposide—testicular cancer	0.000246	0.00127	CcSEcCtD
Azelastine—Conjunctivitis—Doxorubicin—testicular cancer	0.000246	0.00127	CcSEcCtD
Azelastine—Eye disorder—Methotrexate—testicular cancer	0.000245	0.00127	CcSEcCtD
Azelastine—Hypoaesthesia—Epirubicin—testicular cancer	0.000244	0.00127	CcSEcCtD
Azelastine—Asthenia—Cisplatin—testicular cancer	0.000243	0.00126	CcSEcCtD
Azelastine—Pharyngitis—Epirubicin—testicular cancer	0.000243	0.00126	CcSEcCtD
Azelastine—Haematuria—Doxorubicin—testicular cancer	0.000241	0.00125	CcSEcCtD
Azelastine—Epistaxis—Doxorubicin—testicular cancer	0.000238	0.00124	CcSEcCtD
Azelastine—ABCB1—lymph node—testicular cancer	0.000237	0.00457	CbGeAlD
Azelastine—Sinusitis—Doxorubicin—testicular cancer	0.000237	0.00123	CcSEcCtD
Azelastine—Visual impairment—Epirubicin—testicular cancer	0.000236	0.00123	CcSEcCtD
Azelastine—Nausea—Ifosfamide—testicular cancer	0.000234	0.00121	CcSEcCtD
Azelastine—Diarrhoea—Cisplatin—testicular cancer	0.000232	0.0012	CcSEcCtD
Azelastine—Eye disorder—Epirubicin—testicular cancer	0.000229	0.00119	CcSEcCtD
Azelastine—Hypersensitivity—Etoposide—testicular cancer	0.000229	0.00119	CcSEcCtD
Azelastine—Flushing—Epirubicin—testicular cancer	0.000227	0.00118	CcSEcCtD
Azelastine—Rhinitis—Doxorubicin—testicular cancer	0.000227	0.00118	CcSEcCtD
Azelastine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000226	0.00117	CcSEcCtD
Azelastine—Pharyngitis—Doxorubicin—testicular cancer	0.000225	0.00117	CcSEcCtD
Azelastine—Dysgeusia—Methotrexate—testicular cancer	0.000223	0.00116	CcSEcCtD
Azelastine—Asthenia—Etoposide—testicular cancer	0.000223	0.00116	CcSEcCtD
Azelastine—Back pain—Methotrexate—testicular cancer	0.000221	0.00114	CcSEcCtD
Azelastine—Pruritus—Etoposide—testicular cancer	0.00022	0.00114	CcSEcCtD
Azelastine—Visual impairment—Doxorubicin—testicular cancer	0.000219	0.00113	CcSEcCtD
Azelastine—Vomiting—Cisplatin—testicular cancer	0.000216	0.00112	CcSEcCtD
Azelastine—Vision blurred—Methotrexate—testicular cancer	0.000215	0.00111	CcSEcCtD
Azelastine—Rash—Cisplatin—testicular cancer	0.000214	0.00111	CcSEcCtD
Azelastine—Dermatitis—Cisplatin—testicular cancer	0.000214	0.00111	CcSEcCtD
Azelastine—Diarrhoea—Etoposide—testicular cancer	0.000213	0.0011	CcSEcCtD
Azelastine—Eye disorder—Doxorubicin—testicular cancer	0.000212	0.0011	CcSEcCtD
Azelastine—Ill-defined disorder—Methotrexate—testicular cancer	0.000212	0.0011	CcSEcCtD
Azelastine—Flushing—Doxorubicin—testicular cancer	0.00021	0.00109	CcSEcCtD
Azelastine—Tension—Epirubicin—testicular cancer	0.000209	0.00109	CcSEcCtD
Azelastine—Dysgeusia—Epirubicin—testicular cancer	0.000209	0.00108	CcSEcCtD
Azelastine—Nervousness—Epirubicin—testicular cancer	0.000207	0.00108	CcSEcCtD
Azelastine—Back pain—Epirubicin—testicular cancer	0.000206	0.00107	CcSEcCtD
Azelastine—Malaise—Methotrexate—testicular cancer	0.000206	0.00107	CcSEcCtD
Azelastine—Dizziness—Etoposide—testicular cancer	0.000205	0.00107	CcSEcCtD
Azelastine—Vertigo—Methotrexate—testicular cancer	0.000205	0.00106	CcSEcCtD
Azelastine—Nausea—Cisplatin—testicular cancer	0.000201	0.00105	CcSEcCtD
Azelastine—Vision blurred—Epirubicin—testicular cancer	0.000201	0.00104	CcSEcCtD
Azelastine—Cough—Methotrexate—testicular cancer	0.000199	0.00103	CcSEcCtD
Azelastine—Ill-defined disorder—Epirubicin—testicular cancer	0.000198	0.00103	CcSEcCtD
Azelastine—Vomiting—Etoposide—testicular cancer	0.000198	0.00102	CcSEcCtD
Azelastine—Agitation—Epirubicin—testicular cancer	0.000196	0.00102	CcSEcCtD
Azelastine—Rash—Etoposide—testicular cancer	0.000196	0.00102	CcSEcCtD
Azelastine—Dermatitis—Etoposide—testicular cancer	0.000196	0.00102	CcSEcCtD
Azelastine—Headache—Etoposide—testicular cancer	0.000195	0.00101	CcSEcCtD
Azelastine—Myalgia—Methotrexate—testicular cancer	0.000194	0.00101	CcSEcCtD
Azelastine—Chest pain—Methotrexate—testicular cancer	0.000194	0.00101	CcSEcCtD
Azelastine—Tension—Doxorubicin—testicular cancer	0.000194	0.00101	CcSEcCtD
Azelastine—Dysgeusia—Doxorubicin—testicular cancer	0.000193	0.001	CcSEcCtD
Azelastine—Malaise—Epirubicin—testicular cancer	0.000192	0.000998	CcSEcCtD
Azelastine—Discomfort—Methotrexate—testicular cancer	0.000192	0.000995	CcSEcCtD
Azelastine—Nervousness—Doxorubicin—testicular cancer	0.000192	0.000995	CcSEcCtD
Azelastine—Vertigo—Epirubicin—testicular cancer	0.000192	0.000995	CcSEcCtD
Azelastine—Back pain—Doxorubicin—testicular cancer	0.000191	0.000991	CcSEcCtD
Azelastine—Palpitations—Epirubicin—testicular cancer	0.000189	0.000978	CcSEcCtD
Azelastine—Confusional state—Methotrexate—testicular cancer	0.000188	0.000974	CcSEcCtD
Azelastine—Cough—Epirubicin—testicular cancer	0.000186	0.000966	CcSEcCtD
Azelastine—Anaphylactic shock—Methotrexate—testicular cancer	0.000186	0.000965	CcSEcCtD
Azelastine—Vision blurred—Doxorubicin—testicular cancer	0.000186	0.000965	CcSEcCtD
Azelastine—Infection—Methotrexate—testicular cancer	0.000185	0.000959	CcSEcCtD
Azelastine—Nausea—Etoposide—testicular cancer	0.000185	0.000957	CcSEcCtD
Azelastine—Hypertension—Epirubicin—testicular cancer	0.000184	0.000956	CcSEcCtD
Azelastine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000183	0.00095	CcSEcCtD
Azelastine—Myalgia—Epirubicin—testicular cancer	0.000182	0.000943	CcSEcCtD
Azelastine—Chest pain—Epirubicin—testicular cancer	0.000182	0.000943	CcSEcCtD
Azelastine—Agitation—Doxorubicin—testicular cancer	0.000181	0.000941	CcSEcCtD
Azelastine—Anxiety—Epirubicin—testicular cancer	0.000181	0.000939	CcSEcCtD
Azelastine—Discomfort—Epirubicin—testicular cancer	0.000179	0.000931	CcSEcCtD
Azelastine—Malaise—Doxorubicin—testicular cancer	0.000178	0.000924	CcSEcCtD
Azelastine—Dry mouth—Epirubicin—testicular cancer	0.000178	0.000922	CcSEcCtD
Azelastine—Vertigo—Doxorubicin—testicular cancer	0.000177	0.00092	CcSEcCtD
Azelastine—Confusional state—Epirubicin—testicular cancer	0.000176	0.000911	CcSEcCtD
Azelastine—Palpitations—Doxorubicin—testicular cancer	0.000174	0.000905	CcSEcCtD
Azelastine—Anaphylactic shock—Epirubicin—testicular cancer	0.000174	0.000904	CcSEcCtD
Azelastine—Infection—Epirubicin—testicular cancer	0.000173	0.000898	CcSEcCtD
Azelastine—Cough—Doxorubicin—testicular cancer	0.000172	0.000894	CcSEcCtD
Azelastine—Hypertension—Doxorubicin—testicular cancer	0.00017	0.000884	CcSEcCtD
Azelastine—Tachycardia—Epirubicin—testicular cancer	0.00017	0.000882	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00017	0.00088	CcSEcCtD
Azelastine—Myalgia—Doxorubicin—testicular cancer	0.000168	0.000872	CcSEcCtD
Azelastine—Chest pain—Doxorubicin—testicular cancer	0.000168	0.000872	CcSEcCtD
Azelastine—Anxiety—Doxorubicin—testicular cancer	0.000168	0.000869	CcSEcCtD
Azelastine—Paraesthesia—Methotrexate—testicular cancer	0.000167	0.000867	CcSEcCtD
Azelastine—Discomfort—Doxorubicin—testicular cancer	0.000166	0.000862	CcSEcCtD
Azelastine—Dyspnoea—Methotrexate—testicular cancer	0.000166	0.000861	CcSEcCtD
Azelastine—Somnolence—Methotrexate—testicular cancer	0.000165	0.000858	CcSEcCtD
Azelastine—Dry mouth—Doxorubicin—testicular cancer	0.000164	0.000853	CcSEcCtD
Azelastine—Confusional state—Doxorubicin—testicular cancer	0.000162	0.000843	CcSEcCtD
Azelastine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000161	0.000836	CcSEcCtD
Azelastine—Fatigue—Methotrexate—testicular cancer	0.00016	0.000832	CcSEcCtD
Azelastine—Infection—Doxorubicin—testicular cancer	0.00016	0.000831	CcSEcCtD
Azelastine—Pain—Methotrexate—testicular cancer	0.000159	0.000826	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000159	0.000823	CcSEcCtD
Azelastine—Tachycardia—Doxorubicin—testicular cancer	0.000157	0.000816	CcSEcCtD
Azelastine—Paraesthesia—Epirubicin—testicular cancer	0.000156	0.000811	CcSEcCtD
Azelastine—Dyspnoea—Epirubicin—testicular cancer	0.000155	0.000806	CcSEcCtD
Azelastine—Somnolence—Epirubicin—testicular cancer	0.000155	0.000803	CcSEcCtD
Azelastine—Feeling abnormal—Methotrexate—testicular cancer	0.000153	0.000796	CcSEcCtD
Azelastine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000152	0.00079	CcSEcCtD
Azelastine—Fatigue—Epirubicin—testicular cancer	0.00015	0.000779	CcSEcCtD
Azelastine—Pain—Epirubicin—testicular cancer	0.000149	0.000773	CcSEcCtD
Azelastine—Constipation—Epirubicin—testicular cancer	0.000149	0.000773	CcSEcCtD
Azelastine—Body temperature increased—Methotrexate—testicular cancer	0.000147	0.000763	CcSEcCtD
Azelastine—Abdominal pain—Methotrexate—testicular cancer	0.000147	0.000763	CcSEcCtD
Azelastine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000147	0.000762	CcSEcCtD
Azelastine—Paraesthesia—Doxorubicin—testicular cancer	0.000145	0.000751	CcSEcCtD
Azelastine—Dyspnoea—Doxorubicin—testicular cancer	0.000144	0.000745	CcSEcCtD
Azelastine—Feeling abnormal—Epirubicin—testicular cancer	0.000144	0.000745	CcSEcCtD
Azelastine—Somnolence—Doxorubicin—testicular cancer	0.000143	0.000743	CcSEcCtD
Azelastine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000142	0.000739	CcSEcCtD
Azelastine—Fatigue—Doxorubicin—testicular cancer	0.000139	0.000721	CcSEcCtD
Azelastine—Pain—Doxorubicin—testicular cancer	0.000138	0.000715	CcSEcCtD
Azelastine—Constipation—Doxorubicin—testicular cancer	0.000138	0.000715	CcSEcCtD
Azelastine—Abdominal pain—Epirubicin—testicular cancer	0.000138	0.000714	CcSEcCtD
Azelastine—Body temperature increased—Epirubicin—testicular cancer	0.000138	0.000714	CcSEcCtD
Azelastine—Hypersensitivity—Methotrexate—testicular cancer	0.000137	0.000711	CcSEcCtD
Azelastine—Asthenia—Methotrexate—testicular cancer	0.000134	0.000693	CcSEcCtD
Azelastine—Feeling abnormal—Doxorubicin—testicular cancer	0.000133	0.000689	CcSEcCtD
Azelastine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000132	0.000684	CcSEcCtD
Azelastine—Pruritus—Methotrexate—testicular cancer	0.000132	0.000683	CcSEcCtD
Azelastine—Hypersensitivity—Epirubicin—testicular cancer	0.000128	0.000666	CcSEcCtD
Azelastine—Abdominal pain—Doxorubicin—testicular cancer	0.000127	0.000661	CcSEcCtD
Azelastine—Body temperature increased—Doxorubicin—testicular cancer	0.000127	0.000661	CcSEcCtD
Azelastine—Diarrhoea—Methotrexate—testicular cancer	0.000127	0.000661	CcSEcCtD
Azelastine—Asthenia—Epirubicin—testicular cancer	0.000125	0.000648	CcSEcCtD
Azelastine—Pruritus—Epirubicin—testicular cancer	0.000123	0.000639	CcSEcCtD
Azelastine—Dizziness—Methotrexate—testicular cancer	0.000123	0.000638	CcSEcCtD
Azelastine—Diarrhoea—Epirubicin—testicular cancer	0.000119	0.000618	CcSEcCtD
Azelastine—Hypersensitivity—Doxorubicin—testicular cancer	0.000119	0.000616	CcSEcCtD
Azelastine—Vomiting—Methotrexate—testicular cancer	0.000118	0.000614	CcSEcCtD
Azelastine—Rash—Methotrexate—testicular cancer	0.000117	0.000609	CcSEcCtD
Azelastine—Dermatitis—Methotrexate—testicular cancer	0.000117	0.000608	CcSEcCtD
Azelastine—Headache—Methotrexate—testicular cancer	0.000117	0.000605	CcSEcCtD
Azelastine—Asthenia—Doxorubicin—testicular cancer	0.000116	0.0006	CcSEcCtD
Azelastine—Dizziness—Epirubicin—testicular cancer	0.000115	0.000597	CcSEcCtD
Azelastine—Pruritus—Doxorubicin—testicular cancer	0.000114	0.000591	CcSEcCtD
Azelastine—Vomiting—Epirubicin—testicular cancer	0.000111	0.000574	CcSEcCtD
Azelastine—Nausea—Methotrexate—testicular cancer	0.000111	0.000573	CcSEcCtD
Azelastine—Diarrhoea—Doxorubicin—testicular cancer	0.00011	0.000572	CcSEcCtD
Azelastine—Rash—Epirubicin—testicular cancer	0.00011	0.00057	CcSEcCtD
Azelastine—Dermatitis—Epirubicin—testicular cancer	0.00011	0.000569	CcSEcCtD
Azelastine—Headache—Epirubicin—testicular cancer	0.000109	0.000566	CcSEcCtD
Azelastine—Dizziness—Doxorubicin—testicular cancer	0.000107	0.000553	CcSEcCtD
Azelastine—Nausea—Epirubicin—testicular cancer	0.000103	0.000537	CcSEcCtD
Azelastine—Vomiting—Doxorubicin—testicular cancer	0.000102	0.000532	CcSEcCtD
Azelastine—Rash—Doxorubicin—testicular cancer	0.000102	0.000527	CcSEcCtD
Azelastine—Dermatitis—Doxorubicin—testicular cancer	0.000102	0.000527	CcSEcCtD
Azelastine—Headache—Doxorubicin—testicular cancer	0.000101	0.000524	CcSEcCtD
Azelastine—Nausea—Doxorubicin—testicular cancer	9.57e-05	0.000497	CcSEcCtD
